CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Restricted Stock Units | +98,710 | 98,710 | ||
| 2023-02-09 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Stock Option (Right to Buy) | +296,130 | 296,130 | ||
| 2023-02-09 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Restricted Stock Units | +98,270 | 98,270 | ||
| 2023-02-09 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Stock Option (Right to Buy) | +294,810 | 294,810 | ||
| 2023-02-09 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +107,370 | 107,370 | ||
| 2023-02-09 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +322,110 | 322,110 | ||
| 2023-02-09 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Restricted Stock Units | +100,370 | 100,370 | ||
| 2023-02-09 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Stock Option (Right to Buy) | +301,100 | 301,100 | ||
| 2023-02-09 | WADE JEFFREY L President and CFO | Grant or award · Restricted Stock Units | +147,340 | 147,340 | ||
| 2023-02-09 | WADE JEFFREY L President and CFO | Grant or award · Stock Option (Right to Buy) | +442,030 | 442,030 | ||
| 2023-02-09 | COATS LONNEL Chief Executive Officer | Grant or award · Restricted Stock Units | +361,150 | 361,150 | ||
| 2023-02-09 | COATS LONNEL Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,083,440 | 1,083,440 | ||
| 2022-08-05 | Invus US Partners LLC Director | Purchase | +147,390 | $2.50 | $368K | 5,451,204 |
| 2022-08-05 | Artal International S.C.A. Director | Purchase | +2,426,070 | $2.50 | $6.1M | 50,859,331 |
| 2022-08-01 | DEBBANE RAYMOND Director | Purchase | +982,600 | $2.50 | $2.5M | 5,303,814 |
| 2022-08-01 | Invus US Partners LLC Director | Purchase | +982,600 | $2.50 | $2.5M | 5,303,814 |
| 2022-08-01 | Artal International S.C.A. Director | Purchase | +16,173,800 | $2.50 | $40.4M | 48,433,261 |
| 2022-05-21 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +14,402 | 14,402 | ||
| 2022-05-21 | Swain Judith L Director | Grant or award · Restricted Stock Units | +9,302 | 9,302 | ||
| 2022-05-21 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +14,402 | 14,402 |
Page 21 of 27 · 540 trades